Latest Breaking News On - Mural oncology plc - Page 1 : comparemela.com

Alkermes: Additional Narcolepsy Data Could Lead Way To Next Stage (NASDAQ:ALKS)

Alkermes: Additional Narcolepsy Data Could Lead Way To Next Stage (NASDAQ:ALKS)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Harmony biosciences holdings incWorld sleep congressMural oncology plcTreatment of patients withMural oncologyHarmony biosciences holdings

Alkermes spinout Mural Oncology launches with lead IL-2 drug

A year after Alkermes plc announced it would divide its oncology and neuroscience efforts into two separate businesses, the Dublin-based company spun out Mural Oncology plc with $275 million in funding and the lead solid tumor candidate nemvaleukin alfa. Shares of Mural (NASDAQ:MURA) will begin trading Nov. 16. “We’re very excited,” Mural’s CEO Caroline Loew told BioWorld. “We’ve got two major clinical datapoints in the next 18 months.”

Caroline loewMural oncologyAlkermes plcMural oncology plcOil 2Nemvaleukin alfaOvarian cancerInterleukin 2Platinum resistant ovarian cancerMucosal melanoma